Human medicines European public assessment report (EPAR): Clopidogrel Taw Pharma (previously Clopidogrel Mylan), clopidogrel, Date of authorisation: 21/09/2009, Revision: 21, Status: Authorised
Clopidogrel Taw Pharma is available as tablets. The standard dose is 75 mg once a day.
In acute coronary syndrome, treatment generally starts with a loading dose of 300 mg. This is then followed by the standard 75 mg dose once a day for between 4 weeks and up to 12 months.
Clopidogrel Taw Pharma can only be obtained with a prescription.
For more information about using Clopidogrel Taw Pharma, see the package leaflet or contact your doctor or pharmacist.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
